Microbial cis-3-Hexenol Pathway Using Hexanoic Acid Feedstock
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing cis-3-hexenol, a valuable fragrance and flavorant, are not sustainable, scalable, or cost-effective, as they often start from complex fatty acids like linolenic acid and produce undesirable byproducts.
Innovation Solution
A novel, fully synthetic biosynthetic pathway using microbial host cells expressing recombinant enzymes such as acyl-CoA synthetase, short chain acyl-CoA oxidase, enoyl-CoA isomerase, fatty acyl-CoA reductase, and alcohol dehydrogenase to convert hexanoic acid into cis-3-hexenol, bypassing natural pathways that use linolenic acid.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If natural pathways using linolenic acid are used to produce cis-3-hexenol, then the production process is simpler, but the method produces undesirable byproducts and is not cost-effective
Solution Approach 1:
The patent extracts and isolates specific enzymatic functions from the complex natural pathway. By separating the pathway into discrete enzymatic steps (acyl-CoA synthetase, acyl-CoA oxidase, enoyl-CoA isomerase, fatty acyl-CoA reductase, alcohol dehydrogenase), the invention removes the problematic byproduct formation steps while retaining the desired cis-3-hexenol production function, thereby eliminating harmful factors without sacrificing manufacturing simplicity
Solution Approach 2:
The patent changes the chemical parameters of the starting material and pathway intermediates. By using hexanoic acid instead of linolenic acid and controlling the oxidation state and stereochemistry at each step through specific enzymes, the invention transforms the pathway to produce only cis-3-hexenol without unwanted byproducts, achieving both simplicity and purity
2Productivity
If conventional synthesis methods are used, then production cost is reduced, but sustainability and scalability are compromised
Solution Approach 1:
The patent employs a self-service approach by using microbial host cells that autonomously perform the multi-step conversion pathway. The host cell's metabolic machinery, combined with the introduced enzymes, automatically converts hexanoic acid to cis-3-hexenol through a series of controlled enzymatic reactions, eliminating the need for energy-intensive conventional chemical synthesis while maintaining scalability
Solution Approach 2:
The patent replaces mechanical/chemical synthesis methods with biological enzymatic processes. By substituting conventional chemical reactions with enzyme-catalyzed transformations (acyl-CoA synthetase, oxidase, isomerase, reductase, dehydrogenase), the invention achieves greener, more sustainable production that is inherently scalable and energy-efficient
3Productivity
If complex fatty acids like linolenic acid are used as starting materials, then the natural pathway is utilized, but the production process becomes less efficient and produces byproducts
Solution Approach 1:
The patent segments the biosynthetic pathway into distinct enzymatic modules, each responsible for a specific transformation step. By dividing the complex conversion into separate functions (hexanoic acid activation by acyl-CoA synthetase, oxidation by acyl-CoA oxidase, isomerization by enoyl-CoA isomerase, reduction by fatty acyl-CoA reductase, and final reduction by alcohol dehydrogenase), the invention simplifies the overall process control and increases efficiency while avoiding byproduct formation
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for the cost-effective and sustainable production of cis-3-hexenol, suitable for industrial applications in fragrances, cosmetics, and food products, by utilizing simpler starting materials and avoiding unwanted byproducts.
Implementation Method 1
an acyl-CoA synthetase (ACS) converting hexanoic acid to hexanoyl-CoA
Implementation Method 2
a short chain acyl-CoA oxidase (AOX) converting the hexanoyl-CoA to trans-2-hexenoyl-CoA
Implementation Method 3
an enoyl-CoA isomerase (ECI) converting the trans-2-hexenoyl-CoA to cis-3-hexenoyl-CoA
Implementation Method 4
a fatty acyl-CoA reductase (FAR) converting the cis-3-hexenoyl-CoA to cis-3-hexenal
Implementation Method 5
an alcohol dehydrogenase (ADH) converting the cis-3-hexenal to cis-3-hexenol
Data Source
AI summary
The present disclosure relates, in part, to microbial hosts capable of synthesizing cis-3-hexenol, cis-3-hexenal, trans-3-hexenol, trans-3-hexenal, trans-2-hexenal, cis-2-hexenal and related compounds from hexanoic acid and methods for the preparation of cis-3-hexenol, cis-3-hexenal, trans-3-hexenol, trans-3-hexenal, trans-2-hexenal, cis-2-hexenal and related compounds.